Ivy Tonnu-Mihara

412 total citations
19 papers, 227 citations indexed

About

Ivy Tonnu-Mihara is a scholar working on Epidemiology, Hepatology and General Health Professions. According to data from OpenAlex, Ivy Tonnu-Mihara has authored 19 papers receiving a total of 227 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 9 papers in Hepatology and 4 papers in General Health Professions. Recurrent topics in Ivy Tonnu-Mihara's work include Liver Disease Diagnosis and Treatment (10 papers), Hepatitis C virus research (9 papers) and Hepatitis B Virus Studies (6 papers). Ivy Tonnu-Mihara is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Hepatitis C virus research (9 papers) and Hepatitis B Virus Studies (6 papers). Ivy Tonnu-Mihara collaborates with scholars based in United States, United Kingdom and New Zealand. Ivy Tonnu-Mihara's co-authors include Jeffrey S. McCombs, Yong Yuan, P. Hines, Sammy Saab, Timothy Juday, Gilbert L’Italien, D. Steven Fox, Elbert S. Huang, Tianyi Lu and Rebecca Myerson and has published in prestigious journals such as Journal of Hepatology, American Journal of Kidney Diseases and Health Affairs.

In The Last Decade

Ivy Tonnu-Mihara

18 papers receiving 227 citations

Peers

Ivy Tonnu-Mihara

HEPAT

EPIDE

GHP

Catriona Crossan United Kingdom

Ivan Gardini Italy

Alicia Carver United States

Mina Kabiri United States

Chanda Ho United States

Franco Wing Tak Cheng Hong Kong

Jorge Santana Álvarez United States

Andrea C. Hall United States

Sylvester Chuks Nwokediuko Nigeria

Gloria Ashuntantang Cameroon

Catriona Crossan United Kingdom

Ivy Tonnu-Mihara

187 ×1.3

HEPAT

239 ×1.8

EPIDE

40 ×1.3

19 ×0.8

GHP

2 ×0.1

Citations per year, relative to Ivy Tonnu-Mihara Ivy Tonnu-Mihara (= 1×) peers Catriona Crossan

Countries citing papers authored by Ivy Tonnu-Mihara

Since Specialization

Citations

This map shows the geographic impact of Ivy Tonnu-Mihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivy Tonnu-Mihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivy Tonnu-Mihara more than expected).

Fields of papers citing papers by Ivy Tonnu-Mihara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivy Tonnu-Mihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivy Tonnu-Mihara. The network helps show where Ivy Tonnu-Mihara may publish in the future.

Co-authorship network of co-authors of Ivy Tonnu-Mihara

This figure shows the co-authorship network connecting the top 25 collaborators of Ivy Tonnu-Mihara. A scholar is included among the top collaborators of Ivy Tonnu-Mihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivy Tonnu-Mihara. Ivy Tonnu-Mihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Charlton, Michael, et al.. (2024). The clinical and economic burdens of metabolic dysfunction-associated steatohepatitis. Journal of Medical Economics. 27(1). 919–930.

Charlton, Michael, et al.. (2024). Evaluating the burden of illness of metabolic dysfunction–associated steatohepatitis in a large managed care population: The ETHEREAL Study. Journal of Managed Care & Specialty Pharmacy. 30(12). 1414–1430. 1 indexed citations

Tonnu-Mihara, Ivy, et al.. (2023). SA42 Innovative Methods for Integrating Social Determinants of Health Data with Administrative Claims to Facilitate Health Equity Research. Value in Health. 26(6). S404–S405. 1 indexed citations

Lam, Jenny, Ivy Tonnu-Mihara, Nicholas J. Kenyon, & Brooks Kuhn. (2021). Comparative Effectiveness of Roflumilast and Azithromycin for the Treatment of Chronic Obstructive Pulmonary Disease. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 8(4). 450–463. 3 indexed citations

Myerson, Rebecca, Tianyi Lu, Ivy Tonnu-Mihara, & Elbert S. Huang. (2018). Medicaid Eligibility Expansions May Address Gaps In Access To Diabetes Medications. Health Affairs. 37(8). 1200–1207. 22 indexed citations

Harada, Nancy D., Kathryn Wirtz Rugen, Judith L. Bowen, et al.. (2018). Interprofessional transformation of clinical education: The first six years of the Veterans Affairs Centers of Excellence in Primary Care Education. Journal of Interprofessional Care. 37(sup1). S86–S94. 14 indexed citations

McCombs, Jeffrey S., et al.. (2016). The Impact of Delayed Hepatitis C Viral Load Suppression on Patient Risk: Historical Evidence from the Veterans Administration. Forum for Health Economics & Policy. 19(2). 333–351. 5 indexed citations

Fox, D. Steven, et al.. (2016). Comparative treatment effectiveness of direct acting antiviral regimens for hepatitis C: Data from the Veterans administration. Journal of Gastroenterology and Hepatology. 32(6). 1136–1142. 24 indexed citations

Fox, Simon A., et al.. (2016). Analysis of the Impact of HIV Co-Infection on Hepatitis C Treatment Effectiveness for Patients Using New Direct-Acting Antivirals. Journal of Hepatology. 64(2). S219–S220. 1 indexed citations

10.

Tonnu-Mihara, Ivy, Sammy Saab, P. Hines, et al.. (2016). Five Laboratory Tests Predict Patient Risk and Treatment Response in Hepatitis C: Veterans Affairs Data from 1999-2010. 4(1). 10–20. 2 indexed citations

11.

Fox, Simon A., et al.. (2016). Analysis of the Real-World Effectiveness of Direct Acting Antiviral Treatments for Hepatitis C in a Large Population. Journal of Hepatology. 64(2). S217–S217. 4 indexed citations

12.

McCombs, Jeffrey S., Ivy Tonnu-Mihara, Sammy Saab, et al.. (2016). Using the Fib-4 Score to Monitor Morbidity and Mortality Risk in Chronic Hepatitis C Patients. 3 indexed citations

13.

Tonnu-Mihara, Ivy, et al.. (2015). Can hepatitis c treatment be safely delayed?: evidence from the veterans administration healthcare system. Value in Health. 18(3). A245–A245. 3 indexed citations

14.

McCombs, J.S., et al.. (2015). O003 : Can hepatitis c treatment be safely delayed? evidence from the veterans administration healthcare system. Journal of Hepatology. 62. S191–S191. 10 indexed citations

15.

Tonnu-Mihara, Ivy, et al.. (2014). O37 EXTERNAL VALIDATION OF THE RISK-PREDICTION MODEL FOR HEPATOCELLULAR CARCINOMA [HCC] FROM THE REVEAL-HCV STUDY USING DATA FROM THE U.S. VETERANS AFFAIRS [VA] HEALTH SYSTEM. Journal of Hepatology. 60(1). S16–S16. 1 indexed citations

16.

McCarren, Madeline, et al.. (2013). Improvement of Guideline Beta-Blocker Prescribing in Heart Failure: A Cluster-Randomized Pragmatic Trial of a Pharmacy Intervention. Journal of Cardiac Failure. 19(8). 525–532. 10 indexed citations

17.

Aspinall, Sherrie L., Kenneth J. Smith, Chester B. Good, et al.. (2013). Incremental Cost Effectiveness of Pharmacist-Managed Erythropoiesis-Stimulating Agent Clinics for Non-Dialysis-Dependent Chronic Kidney Disease Patients. Applied Health Economics and Health Policy. 11(6). 653–660. 6 indexed citations

18.

McCombs, Jeffrey S., Ivy Tonnu-Mihara, Sammy Saab, et al.. (2013). The Risk of Long-term Morbidity and Mortality in Patients With Chronic Hepatitis C. JAMA Internal Medicine. 174(2). 204–204. 97 indexed citations

19.

Aspinall, Sherrie L., Francesca Cunningham, Xinhua Zhao, et al.. (2012). Impact of Pharmacist-Managed Erythropoiesis-Stimulating Agents Clinics for Patients With Non–Dialysis-Dependent CKD. American Journal of Kidney Diseases. 60(3). 371–379. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact